Content about Von Willebrand factor

January 12, 2012
Octapharma USA hires former Baxter BioScience executive

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

HOBOKEN, N.J. — Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

August 2, 2010
Octapharma gets orphan drug status for Wilate

The Food and Drug Administration has given orphan drug designation to a treatment for an...

May 12, 2010
Octapharma launches bleeding disorder treatment

A drug for treating the bleeding disorder von Willebrand disease has become available, manufacturer Octapharma...